These changes may occur both globally and at specific loci such as the Insulin-like Growth Factor-2 (IGF-2) gene, where a decrease in DNA methylation is associated with the risk of obesity, dyslipidemia and insulin resistance in adulthood [101]. Here, IGF2 is linked to metabolic syndrome.